Superpower

Overview
News
Longevity Tech?
Product stageSegments
Pre-Seed
?
Diagnostics and lifestyle
?

Superpower is a healthcare platform that aims to provide personalized, preventative, and longevity-focused medicine through a digital-first approach. Instead of the traditional reactive model of treating diseases after they occur, Superpower offers comprehensive annual health assessments that go beyond standard primary care physicals. These assessments cover various aspects such as nutrition, sleep, gut health, hormones, and toxins, which are often neglected in traditional healthcare.

By combining whole-body testing, AI-assisted concierge clinicians, and a curated ecosystem of treatments, Superpower seeks to become a lifelong health partner for individuals. The platform utilizes data insights to tailor health strategies for each member, continually adapting and evolving based on their unique needs.

Superpower has established a nationwide network integrated with hundreds of testing and treatment partners. It has also rolled out a beta membership model to provide its services. As of May 2024, the company had opened a waitlist with over 15,000 signups and planned to onboard new members weekly throughout the remainder of the year.

In May 2024, Superpower announced that it had raised USD 4 million in pre-seed funding led by Susa Ventures, with participation from several other venture capital firms and angel investors. The company was founded in early 2023 by serial entrepreneurs Kevin Unkrich, Max Marchione, and Jacob Peters, whose previous ventures were valued at over USD 500 million.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
11209 National Blvd Unit #1016 Los Angeles California, United States Los Angeles CA USA
Founded year:
2022
Employees:
11-50
IPO status:
Private
Total funding:
USD 4.0 mn
Last Funding:
USD 4.0 mn (Pre Seed; Apr 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.